Search the Community
Showing results for tags 'myopathy'.
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. Using HEp-2 IIF patterns, three novel clinicoserological subsets of scleromyositis emerged. PubMed, RMD Open, 2020 Sep;6(2):e001357. (Also see Myopathy and Myositis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.